CHA News

FDA Authorizes Booster Doses for Moderna, Johnson & Johnson COVID-19 Vaccines 

For CEOs, CMOs, CNOs, COOs, and infection prevention, quality & patient safety, employee safety staff

This post has been archived and contains information that may be out of date.

The Food and Drug Administration (FDA) has amended emergency use authorization (EUA) for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines. Specifically, the EUA allows for a single-dose booster in the following circumstances:  Ages 65 and older Ages 18-64 at high risk of severe COVID-19  Ages 18-64 with frequent institutional or occupational exposure to SARS-CoV-2  The use of a...

This content is restricted to members.